Aether

📍 Menlo Park, United States🗓 Founded 2017👥 84 employees💰 Last funded Aug 2023
Biotechnology Research🌐 aetherbio.com
Website LinkedIn
Aether Biomachines is an American artificial intelligence company that discovers proteins with high-impact, real-world applications. At the core of its work is a Protein Function Model that can unlock new proteins for novel functions. Aether’s AI is being built on an entirely proprietary dataset developed in-house through advanced high-throughput screening and innovative assay technology. Using this platform, Aether has developed seven new classes of proteins with capabilities ranging from refining metals at lower cost and breaking down persistent “forever chemicals” to producing industry-leading materials, enabling complex pharmaceutical manufacturing, recycling plastics, and capturing carbon dioxide. Aether is already translating its AI breakthroughs into practice, commercializing high-performance materials that can print ten times faster than current industry benchmarks while offering superior strength for the defense and aerospace industries.
8
Total investors
3
Early stage
3
Mid stage
2
Late stage
2017
Founded

Investors

8 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
7
Germany
1
Investor activity2017–2023 · investors recorded per year
201712018120191202012021220232
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Aether?
Aether has 8 investors on record on gritt.io, including 3 early-stage backers, 3 mid-stage and 2 late-stage investors.
When did Aether last raise funding?
The most recent investment in Aether recorded on gritt.io was in August 2023.
When was Aether founded?
Aether was founded in 2017.
What industry is Aether in?
Aether operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Aether based?
Aether is headquartered in Menlo Park, United States.